2.47
2.37%
-0.06
Handel nachbörslich:
2.46
-0.01
-0.40%
Finanzdaten der Phio Pharmaceuticals Corp-Aktie (PHIO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
16.32%
2.209
|
1.899 | 2.776 | 2.547 | 3.602 |
Operating Income/Loss |
16.32%
-2.209
|
-1.899 | -2.776 | -2.547 | -3.602 |
Nonoperating Income/Loss |
1,275%
0.055
|
0.004 | -0.004 | -0.002 | - |
Income/Loss From Continuing Operations Before Tax |
13.67%
-2.154
|
-1.895 | -2.78 | -2.549 | -3.602 |
Income/Loss From Continuing Operations After Tax |
13.67%
-2.154
|
-1.895 | -2.78 | -2.549 | -3.602 |
Net Income/Loss
|
13.67%
-2.154
|
-1.895 | -2.78 | -2.549 | -3.602 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,385%
4.5801
|
0.3085 | 2.4402 | 1,728.49 | 1.1422 |
Diluted Average Shares |
1,385%
4.5801
|
0.3085 | 2.4402 | 1,728.49 | 1.1422 |
Basic Earnings Per Share |
176.47%
-0.47
|
-0.17 | -1.14 | -1.47 | -3.15 |
Diluted Earnings Per Share |
176.47%
-0.47
|
-0.17 | -1.14 | -1.47 | -3.15 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):